Menu

Provider Webinar Series

In a webinar series designed for healthcare providers who are involved in the care of individuals living with Tourette Syndrome, the TAA has identified relevant topics to support the community’s needs. The series covered diagnosis, management, treatment as well as discussions of Tourette Syndrome’s co-occurring conditions such as OCD and ADHD. CME credit is available upon completion.

ACCME Accreditation Statement

These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Warren Alpert Medical School of Brown University and the Tourette Association of America. The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.

Click on each course title for full accreditation information.

Method of Participation

  • There are no fees for participating in and receiving credit for this activity.
  • Review the activity objectives, faculty information, and CME information prior to participating in the activity.
  • View the CME presentations.
  • Complete the CME activity evaluation at the conclusion of the activity, select desired credit type and then gain immediate access to your certificate.

Diagnosing Tourette Syndrome and Initial Considerations

Presenter: Dr. John Walkup
Description: This webinar was suitable for all providers who are interested in working with patients dealing with Tourette Syndrome.

Bio

Dr. John T. Walkup is Professor of Psychiatry, Northwestern Feinberg School of Medicine and Chair, the Department of Child and Adolescent Psychiatry, Ann and Robert H. Lurie Children’s Hospital of Chicago. He recently moved to Northwestern after being the Division Director of Child and Adolescent Psychiatry at Weill Cornell Medical College in New York City. He is also an Adjunct Professor in the Center for American Indian Health at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine.

Dr. Walkup is one of a very small and elite group of academic child and adolescent psychiatrists in the United States. His work covers three main areas of innovation and investigation. His work with movement disorders, specifically Tourette syndrome, uniquely spans psychiatry, child psychiatry and neurology. His expertise in child and adolescent psychiatry clinical trials focuses on the development and evaluation of psychopharmacological and psychosocial treatments and lastly, he has been involved in developing and evaluating interventions to reduce the large mental health disparities facing Native American youth, specifically drug use and suicide prevention. Over his career, Dr. Walkup has been awarded over $20 million in grants and contracts to support his research.

His capacity to apply research methodologies across numerous neuropsychiatric disorders and his extension of that skill to address mental health disparities in Native American youth make him a singularly unique contributor to psychiatry, neurology and public health.

For his work, he has been awarded three United States achievement awards for child and adolescent psychiatry, the Norbert and Charlotte Rieger Award for Academic Achievement in 2009 from the American Academy of Child and Adolescent Psychiatry, the Blanche F. Ittleson Award for Research in Child Psychiatry in 2011 from the American Psychiatric Association and the Schonfeld Award from the American Society of Adolescent Psychiatry in 2016.

A recent paper of his (Walkup JT. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies. Am J Psychiatry. 2017 May 1;174(5):430-437 was considered by the editor of the American Journal of Psychiatry, Robert Freedman, MD, his choice for ‘Paper of the Year’. He has also served as a member of two National Academy (IOM) Committees on Developing Evidence-Based Standards for Psychosocial Interventions for Mental Disorders and Improving Health Outcomes for Children with Disabilities. He currently serves as a Counselor-at-Large for the American Academy of Child and Adolescent Psychiatry. He is also a Member of the Board of Director of the Tourette Association of America.

Evidence-Based Treatment and Management of Tourette Syndrome

Presenter: Dr. Tamara Pringsheim
Description: Based upon the recently published American Academy of Neurology guidelines on the treatment of tics, this webinar will guide providers on the comprehensive evaluation of people with tics, including assessment of comorbid disorders. The evidence to support the use of behavioral therapies and pharmacological treatments for tics will be reviewed, with discussion of how to safely prescribe these interventions in clinical practice.

Bio

Dr. Tamara Pringsheim is an Associate Professor with the Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences at the University of Calgary. She is the program lead for the Tourette and Pediatric Movement Disorder program at Alberta Children’s Hospital and the Deputy Director of the Mathison Centre for Mental Health Research and Education. She also works as an evidence-based medicine methodologist for the American Academy of Neurology.

Dr. Pringsheim completed her residency in neurology at the University of Toronto and a fellowship in movement disorders and neuropsychiatry at the Toronto Western Hospital, and her Master of Science in Clinical Epidemiology. Her research program is focused on rational pharmacotherapy for neurological and mental health disorders, using knowledge synthesis and translation strategies.

She has developed clinical practice guidelines and tools for clinicians, and nationally implemented educational curricula with the goal of improving the safety, effectiveness and appropriateness of care.

Providing CBIT via Tele-health

Presenters: Dr. Matthew Capriotti and Dr. Christine Conelea
Description: In this webinar, Dr. Matthew Capriotti and Dr. Christine Conelea, two CBIT experts, discussed and demonstrated keys to providing thoughtful, high-quality CBIT treatment to clients via telehealth. They briefly overviewed teletherapy basics, with specific considerations for providing teletherapy in the context of the COVID-19 crisis. They also demonstrated how to implement CBIT effectively over videoconferencing, commenting on specific adaptations and considerations for telehealth.

Bios

Dr. Matthew Capriotti is a licensed clinical psychologist and an Assistant Professor of Psychology at San José State University (SJSU).  He holds his Ph.D. in psychology from the University of Wisconsin-Milwaukee (2015) and completed pre- and post-doctoral fellowships in the Department of Psychiatry at the University of California San Francisco (2014-2016). Recently, Dr. Capriotti recently conducted a clinical trial of in-home teleCBIT, funded by a Clinical Research Training Fellowship from the Tourette Association of America and the American Academy of Neurology. He also co-led the Treating Tourette Together project, which brought together people with Tourette Syndrome, their families, clinicians, researchers, and other stakeholders to set an agenda for the next generation of CBIT research. Over the last decade, Dr. Capriotti has published 31 scientific journal articles and 7 book chapters on Tourette Syndrome, obsessive-compulsive spectrum disorders, and on LGBTQ+ mental health.

Christine Conelea, Ph.D., is an assistant professor in the Department of Psychiatry and Behavioral Sciences at the University of Minnesota and a licensed psychologist. She received her doctorate in psychology from the University of Wisconsin-Milwaukee in 2011 and completed a fellowship in child mental health at the Alpert Medical School of Brown University in 2014. She has over 50 publications on the topics of tics, OCD, and anxiety, and her research in these areas has been funded by the NIH. Dr. Conelea currently co-directs the Converging Approaches to Neurodevelopment Lab, which focuses on using dimensional approaches to study the causes and treatment of neurodevelopmental disorders, including tic disorders, OCD, ADHD, and autism. She also studies dissemination of evidence-based treatments and strategies for integrating neuroscience and behavioral methods to improve mental health.

She has developed clinical practice guidelines and tools for clinicians, and nationally implemented educational curricula with the goal of improving the safety, effectiveness and appropriateness of care.